Title | Adjuvant Therapy of Breast Cancer [electronic resource] / edited by I. Craig Henderson |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 1992 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-3496-9 |
Descript | XVI, 464 p. online resource |
I. Rationale and Methods for Studying Adjuvant Systemic Therapy -- 1. Evolving concepts in the adjuvant systemic therapy of operable breast cancer -- 2. Statistical methods for early breast cancer trials -- II. Results of Clinical Studies -- 3. The nature of the benefit -- 4. Adjuvant endocrine therapy of breast cancer -- 5. Adjuvant chemotherapy of axillary lymph-node-positive breast cancer -- 6. The node-negative problem: To treat or not to treat -- III. Special Problems -- 7. Defining the high-risk breast cancer patient -- 8. Models for weighing benefits and toxicities -- 9. Financial considerations in the use of adjuvant chemotherapy -- 10. The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy -- 11. Treating the relapsed patient -- IV. Future Directions -- 12. Unanswered questions in the adjuvant therapy of breast cancer -- 13. Neoadjuvant chemotherapy -- 14. Altering cell kinetics with endocrine therapy -- 15. Polypeptide growth factors: Their potential value in the management of breast cancer patients -- 16. Immunotherapy of breast cancer -- 17. Breast cancer chemoprevention -- Appendices -- I. Consensus statements from panels convened by The National Cancer Institute in 1980, 1985, 1990 -- II. List of completed and ongoing randomized clinical trials addressing questions related to the use of adjuvant systemic therapy to treat resectable breast cancer